Keywords: Aegerion Pharma, Lomitapide, HoFH, Genetic disorder, USA, Europe

Aegerion files for lomitapide approval in USA and Europe

Article | 07 March 2012

Print This

Emerging US biotech firm Aegerion Pharmaceuticals (Nasdaq: AEGR) has submitted a New Drug Application to the US Food and Drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in